hit counter
Agilent Technologies, Inc. (A) Stock News Sentiment & Price - Sentifly
A - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Agilent Technologies, Inc. (A)

USA
Medical Laboratories & Research
NYSE
A Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
A Latest news
Business Wire
Neutral
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
2021-10-21 08:31

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received CE-IVD mark approval for the PD-L1 IHC 28-8 pharmDx to guide options for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal cancers. Gastric (stomach) cancer is the fifth most common cancer and the fourth leading cause of cancer death worldwide, with over 1,000,000 new cases and approximately 770,000 deaths

Zacks Investment Research
Positive
ETFs to Ride on a Solid Start to Q3 Earnings
2021-10-20 11:40

The rounds of upbeat earnings has set the stage for the S&P 500 Index to hit new highs as more Q3 earnings unfold.

Zacks Investment Research
Neutral
5 Best Performing Stocks of the S&P 500 ETF Last Week
2021-10-18 16:42

The S&P 500 Index wrapped up its best week since July, climbing 1.8% on encouraging quarterly earnings releases from several companies

Business Wire
Neutral
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
2021-10-13 16:16

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered. This is the first IHC assay measuring Ki-67 expression to receive FDA approval in the context of treatment with Verzenio and was de

Business Wire
Neutral
Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)
2021-09-28 08:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced Professor Bernhard Lendl has been selected to receive a prestigious Agilent Thought Leader Award. Highly renowned in the field of vibrational spectroscopy, Dr. Lendl is a professor at the TU Wien (Vienna) and head of the working group on Process Analysis & Vibrational Spectroscopy at the institution. Professor Lendl's work focuses on adapting powerful spectroscopic techniques and unique combinations of

Seeking Alpha
Neutral
Dividend Champion And Contender Highlights: Week Of September 26
2021-09-26 02:57

A weekly summary of dividend activity for Dividend Champions and Contenders.

Business Wire
Neutral
Dr. Mikael Dolsten Named to Agilent Board of Directors
2021-09-23 16:05

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Pfizer executive Dr. Mikael Dolsten appointed to Agilent board of directors.

Business Wire
Neutral
Agilent Announces Cash Dividend of 19.4 Cents per Share
2021-09-22 16:05

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces dividend.

Zacks Investment Research
Positive
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
2021-09-17 10:42

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

The Motley Fool
Neutral
Investing in Water ETFs
2021-09-16 13:33

An in-depth look at the leading water ETFs in the U.S stock market.

Loading more news...